(Q43105087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

0 references

1 reference

1 reference

Theodosios D. Filippatos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Moses Elisaf

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

E S Nakou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

A P Agouridis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

C Kostara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

E T Bairaktari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

1 reference

9 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

445-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein

30 January 2020

cites work

1 reference

12 December 2020

Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women

1 reference

12 December 2020

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

1 reference

12 December 2020

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

1 reference

12 December 2020

Orlistat-associated adverse effects and drug interactions: a critical review

1 reference

12 December 2020

Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.

1 reference

12 December 2020

Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients

1 reference

12 December 2020

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

1 reference

12 December 2020

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes

1 reference

12 December 2020

The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome

1 reference

12 December 2020

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice

1 reference

12 December 2020

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

12 December 2020

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study

1 reference

12 December 2020

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

1 reference

12 December 2020

A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia

1 reference

12 December 2020

Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level

1 reference

12 December 2020

Apolipoprotein E-mediated binding of hypertriglyceridemic very low density lipoproteins to isolated low density lipoprotein receptors detected by ligand blotting

1 reference

12 December 2020

Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus

1 reference

12 December 2020

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

12 December 2020

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

1 reference

12 December 2020

Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.

1 reference

12 December 2020

Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli

1 reference

12 December 2020

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia

1 reference

12 December 2020

Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice

1 reference

12 December 2020

Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.

1 reference

12 December 2020

Phenotypes, genotypes and response to statin therapy

1 reference

12 December 2020

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

1 reference

12 December 2020

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

1 reference

12 December 2020

Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study

1 reference

12 December 2020

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

1 reference

12 December 2020

Structure and functional properties of apolipoprotein C-II

1 reference

12 December 2020

Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia

1 reference

12 December 2020

Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E

1 reference

12 December 2020

Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins

1 reference

12 December 2020

1 reference

12 December 2020

Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions

1 reference

12 December 2020

Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.

1 reference

12 December 2020

Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia

1 reference

12 December 2020

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

1 reference

12 December 2020

Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes

1 reference

12 December 2020

Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III

1 reference

12 December 2020

The effects of orlistat on metabolic parameters and other cardiovascular risk factors.

1 reference

12 December 2020

LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients

1 reference

12 December 2020

Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II

1 reference

12 December 2020

Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.

1 reference

12 December 2020

Lipid-lowering drugs acting at the level of the gastrointestinal tract

1 reference

12 December 2020

Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndrome

1 reference

12 December 2020

10.1007/S11745-010-3409-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20379853%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference